Literature DB >> 19996115

The significance of monoclonal gammopathy of undetermined significance.

Robert A Kyle, Shaji Kumar.   

Abstract

Mesh：

Year:  2009        PMID： 19996115      PMCID： PMC2791927          DOI： 10.3324/haematol.2009.013961

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  21 in total

1.  Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance.

Authors:  H Gregersen; J Ibsen; L Mellemkjoer; J Dahlerup; J Olsen; H T Sørensen
Journal:  Br J Haematol       Date:  2001-02       Impact factor: 6.998

2.  Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting.

Authors:  J Singh; A W Dudley; K A Kulig
Journal:  J Lab Clin Med       Date:  1990-12

3.  A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew F Plevak; L Joseph Melton
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

Review 4.  Monoclonal gammopathies of undetermined significance: a review.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Immunol Rev       Date:  2003-08       Impact factor: 12.988

5.  Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Therese M-L Andersson; Sandra Eloranta; Paul W Dickman; Lynn R Goldin; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

6.  Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Dirk R Larson; Matthew F Plevak; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2004-07       Impact factor: 7.616

7.  Monoclonal gammopathy of undetermined significance. Natural history in 241 cases.

Authors:  R A Kyle
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

8.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

9.  Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands.

Authors:  M H van de Poel; J W Coebergh; H F Hillen
Journal:  Br J Haematol       Date:  1995-09       Impact factor: 6.998

10.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616
View more
  7 in total

1.  CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease.

Authors:  Sarah K Johnson; James P Stewart; Rakesh Bam; Pingping Qu; Bart Barlogie; Frits van Rhee; John D Shaughnessy; Joshua Epstein; Shmuel Yaccoby
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

2.  Effect of HM910, a novel camptothecin derivative, on the inhibition of multiple myeloma cell growth in vitro and in vivo.

Authors:  Juan Li; Yudan Ouyang; Xu Zhang; Wenqiang Zhou; Fang Wang; Zhencong Huang; Xiaokun Wang; Yifan Chen; Hui Zhang; Liwu Fu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 3.  Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma.

Authors:  Adriana Zingone; W Michael Kuehl
Journal:  Semin Hematol       Date:  2011-01       Impact factor: 3.851

Review 4.  Can we change the disease biology of multiple myeloma?

Authors:  Ivan Borrello
Journal:  Leuk Res       Date:  2012-11       Impact factor: 3.156

5.  Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome.

Authors:  Tanjung A Sumekar; Aneel A Ashrani; Tri I Winarni; Randi J Hagerman
Journal:  Case Rep Genet       Date:  2011-12-01

Review 6.  Cellular mechanisms of multiple myeloma bone disease.

Authors:  Angela Oranger; Claudia Carbone; Maddalena Izzo; Maria Grano
Journal:  Clin Dev Immunol       Date:  2013-05-29

7.  Association between the delta estimated glomerular filtration rate and the prevalence of monoclonal gammopathy of undetermined significance in Korean males.

Authors:  Tae-Dong Jeong; Woochang Lee; Sail Chun; Won-Ki Min
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.